Latest News
Share Price / Index
September 01, 2024
Not intended for U.S. and UK - Media Late-Breaking data from pivotal Phase III FINEARTS-HF study presented at ESC Congress 2024
Finerenone showed statistically significant improvement in cardiovascular outcomes in adults with common form of heart failure with high unmet medical need
August 29, 2024
Not intended for UK Media
Bayer starts Phase III trial in non-small cell lung cancer (NSCLC)
August 22, 2024
Not intended for UK Media
The Journal of American Medical Association (JAMA) publishes Elinzanetant Phase III data

Find Your Product

With our products we contribute to the health of people and plants. Here you find an overview of the major Bayer products.